Soligenix
SNGX
$0.32
Share price
-10.00%
Change (1 day)
-56.25%
Change (1 year)
Categories
Soligenix (SNGX) - Net assets
Net assets on the balance sheet as of March 2024 : $0.76 M
According to Soligenix's latest financial reports the company has $0.76 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Soligenix - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-2.48 M | -123.04% |
| 2021-12-31 | $10.72 M | 186.56% |
| 2020-12-31 | $3.74 M | 156.79% |
| 2019-12-31 | $1.45 M | -76.8% |
| 2018-12-31 | $6.28 M | -0.63% |
| 2017-12-31 | $6.31 M | -14.57% |
| 2016-12-31 | $7.39 M | -40502.25% |
| 2015-12-31 | $-0.02 M | -88.1% |
| 2014-12-31 | $-0.16 M | -91.3% |
| 2013-12-31 | $-1.77 M | -149.84% |
| 2012-12-31 | $3.55 M | -47.71% |
| 2011-12-31 | $6.79 M | -7.7% |
| 2010-12-31 | $7.35 M | -9.99% |
| 2009-12-31 | $8.17 M | 313.44% |
| 2008-12-31 | $1.97 M | -23.67% |
| 2007-12-31 | $2.59 M | -333.69% |
| 2006-12-31 | $-1.11 M | -172.54% |
| 2005-12-31 | $1.52 M | -48.78% |
| 2004-12-31 | $2.98 M | -43.11% |
| 2003-12-31 | $5.24 M | 22.38% |
| 2002-12-31 | $4.28 M | -263.02% |
| 2001-12-31 | $-2.63 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 9,112,673.50% | 🇺🇸 USA |
 Pfizer PFE | $92.55 B | 12,045,888.14% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 10,698,285.68% | 🇫🇷 France |
 Onconova Therapeutics ONTX | $6.01 M | 682.82% | 🇺🇸 USA |
 Athersys ATHX | -$36.4 M | -4,836.64% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $7.54 B | 981,585.95% | 🇮🇱 Israel |
 Emergent BioSolutions
EBS | $0.66 B | 86,303.46% | 🇺🇸 USA |